C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
Bomback, Andrew S; Santoriello, Dominick; Avasare, Rupali S; Regunathan-Shenk, Renu; Canetta, Pietro A; Ahn, Wooin; Radhakrishnan, Jai; Marasa, Maddalena; Rosenstiel, Paul E; Herlitz, Leal C; Markowitz, Glen S; D'Agati, Vivette D; Appel, Gerald B.
; 93(4): 977-985, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29310824
Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis.
Short-term outcome of clinical and histopathologic variants of mesangiocapillary glomerulonephritis in children: A retrospective analysis from a tertiary care center.
Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
C3 glomerulopathy in children: Is there still a place for anti-cellular immunosuppression?
Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency.
The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase <i>Îµ</i>.
Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.
Idiopathic membranoproliferative glomerulonephritis: does it exist?
Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.